New Zealand markets close in 4 hours 55 minutes

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
44.15+0.70 (+1.61%)
At close: 04:00PM EDT
44.00 -0.15 (-0.34%)
After hours: 07:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 88.65B
Enterprise value 105.80B
Trailing P/E 15.91
Forward P/E 11.04
PEG ratio (5-yr expected) 1.16
Price/sales (ttm)2.32
Price/book (mrq)5.10
Enterprise value/revenue 3.44
Enterprise value/EBITDA 12.59

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 319.20%
S&P500 52-week change 325.77%
52-week high 344.33
52-week low 333.33
50-day moving average 341.88
200-day moving average 338.17

Share statistics

Avg vol (3-month) 33.36M
Avg vol (10-day) 33.51M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.93B
% held by insiders 10.06%
% held by institutions 114.86%
Shares short (15 Apr 2024) 47.35M
Short ratio (15 Apr 2024) 42.57
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.36%
Shares short (prior month 15 Mar 2024) 43.97M

Dividends & splits

Forward annual dividend rate 41.5
Forward annual dividend yield 43.46%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 31.36%
5-year average dividend yield 44.94
Payout ratio 453.43%
Dividend date 311 Jul 2024
Ex-dividend date 416 May 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.59%
Operating margin (ttm)37.51%

Management effectiveness

Return on assets (ttm)10.06%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)15.15
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 11.23B
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)2.73
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)6.06B